Skip to main content

(Lapsed on 31 August 2020) DEXAFREE dexamethasone sodium phosphate 1 mg/ml eye drops solution in single-dose container

Section 19A approved medicine
(Lapsed on 31 August 2020) DEXAFREE dexamethasone sodium phosphate 1 mg/ml eye drops solution in single-dose container
Section 19A approval holder
HL Pharma Pty Ltd ABN 31 168 013 723
Phone
03 9823 6228
Approved until
Status
Lapsed
Medicines in short supply/unavailable
MINIMS PREDNISOLONE SODIUM PHOSPHATE 0.5% 5mg/mL eye drops ampoule - ARTG 32233
Indication(s)

For treatment of non-infectious inflammatory conditions affecting the anterior segment of the eye.

Additional information

DEXAFREE dexamethasone sodium phosphate 1 mg/ml eye drops solution in single-dose container is not an extract substitute for of MINIMS PREDNISOLONE SODIUM PHOSPHATE (prednisolone) 0.5% 5mg/mL eye drops ampoule as they contain different active ingredients.

Help us improve the Therapeutic Goods Administration site